← Browse by Condition
Medical Condition
neuropathic pain
Total Trials
9
Recruiting Now
9
Trial Phases
Phase 1
Pain clinical trials span acute procedural pain, chronic musculoskeletal pain, neuropathic pain, and cancer-related pain β€” each requiring distinct trial designs and patient-reported outcome instruments. The regulatory demand for non-opioid alternatives has intensified the search for novel analgesic mechanisms, particularly ion channel targets and neurostimulation approaches.
Active trials evaluate Nav1.7/1.8 blockers, CGRP antagonists for new indications, spinal cord stimulation refinements, virtual reality-based pain management, and patient-specific ketamine infusion protocols. Pain trials increasingly use ecological momentary assessment (EMA) diary approaches over traditional recall-based pain rating scales.
Frequently Asked Questions — neuropathic pain Clinical Trials
How many clinical trials are currently recruiting for neuropathic pain?
ClinicalMetric currently tracks 9 actively recruiting clinical trials for neuropathic pain, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 9. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for neuropathic pain?
neuropathic pain research spans Phase 1 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a neuropathic pain clinical trial?
Eligibility criteria for neuropathic pain trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 1
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT05968664
Recruiting
Enrollment
43 pts
Location
United States
Sponsor
Ashwin Viswanathan
NCT07400640
Recruiting
Enrollment
50 pts
Location
Turkey (Türkiye)
Sponsor
Diskapi Teaching and Research ...
NCT05645003
Recruiting
Enrollment
60 pts
Location
Turkey (Türkiye)
Sponsor
Afyonkarahisar Health Sciences...
NCT07342777
Recruiting
Enrollment
116 pts
Location
Denmark
Sponsor
University of Aarhus
NCT06155916
Recruiting
Enrollment
40 pts
Location
Finland
Sponsor
Helsinki University Central Ho...
NCT06044584
Recruiting
Enrollment
150 pts
Location
Italy, Switzerland
Sponsor
ETH Zurich
NCT07211256
Recruiting
Enrollment
70 pts
Location
France
Sponsor
Hospital Ambroise Paré Paris
NCT05492188
Recruiting
Enrollment
15 pts
Location
United States
Sponsor
Medical University of South Ca...
NCT06438471 Phase 1
Recruiting
Enrollment
36 pts
Location
United States
Sponsor
EicOsis Human Health Inc.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology